STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
Vulvar Squamous Cell CarcinomaThis study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?
null
Conditions de participation
-
Sexe:
FEMALE -
Âges admissibles:
18 and up
Critères de participation
Inclusion Criteria:
* Histologically confirmed primary diagnosis of vulvar squamous cell carcinoma (VSCC)
* Surgically staged FIGO I-II VSCC as per FIGO 2021 guidelines
* Vulvar resection according to standard of care guidelines
* Post-operative margin assessment of tumour clearance, dVIN and p53 status.
* Participants' age must be ≥ 18 years old
* Participant is able (i.e. sufficiently fluent) and willing to complete the quality of life and/or health utility questionnaires in either English or French
* Participant's consent must be appropriately obtained in accordance with applicable local and regulatory requirements
Exclusion Criteria:
* Recurrent vulvar squamous cell carcinoma
* Non-squamous cell carcinoma histotypes
* Participants referred for/receiving/or previously received adjuvant vulvar radiation or chemotherapy
* Primary tumour HPV-I p53 wild-type VSCC
* Surgical margins positive for invasive cancer.
* Participants with a history of other malignancies, except: adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumours curatively treated with no evidence of disease for ≥ 5 years
* Lymph node positive VSCC
Lieu de l'étude
BCCA - Vancouver
BCCA - VancouverVancouver, British Columbia
Canada
Contactez l'équipe d'étude
Amy Jamieson
604 729-1258- Étude parrainée par
- Canadian Cancer Trials Group
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT06358469